November 1, 2024 | COVID, Patient Retention, clinical trials, influenza, patient recruitment
Around 86% of clinical trials do not meet patient recruitment goals, ultimately failing to improve patient outcomes and resulting in financial losses for sponsors and research sites (Rangu and Maxwell, 2020). A 2023 study calculated that these financial losses can reach approximately $500,000 in lost drug sales and $40,000 in direct clinical trial costs per day of delay (appliedclinicaltrialsonline.com), so the sites chosen to participate in the trial and the support provided to them during patient recruitment can be one of the major deciding factors between an on-time trial and a delayed, over-budget trial.

🔍 Is Your Influenza Clinical Trial Ready for the Upcoming Flu Season? 🩺
The clock is ticking—flu season is just around the corner! With 86% of clinical trials failing to meet recruitment goals, it’s crucial that your sites are fully prepared to recruit patients effectively.
Our latest blog explores key strategies to enhance site motivation, streamline recruitment processes, and overcome common challenges in patient recruitment. Don’t let delays cost you—read Part #2 of our series to ensure your trial is on track for success this flu season.
🚀 Read the full blog and boost your recruitment strategy today! 👉 https://bit.ly/4cFG7ql
This content was provided by Innovative Trials
Company Details
Latest Content from Innovative Trials
Kate Shaw comments on the latest news about AstraZeneca and Merck’s decision to hold planned investments in the UK
Boosting screening & enrollment rates in a global oncology trial
Clinical trial patient recruitment and retention practices have significantly advanced over the last 15 years thanks to technological innovations and the rise of AI, shifting patient expectations and the increased,…
Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by streamlining the drug development process and helping to generate more robust data, which…
So far this year, we have witnessed several announcements that could have a major impact on the clinical trials market and our global health overall.
Innovative Trials, an internationally renowned clinical trials patient recruitment company based in the UK, has today announced Garden House Hospice Care as its UK charity partner for 2025/26. It continues…
Kate Shaw, founder and CEO of Innovative Trials, has responded to data that shows the UK has far fewer women-only clinical trials compared to male-only studies. Read the full article here.
Join Innovative Trials and Soglia in this new patient recruitment and retention webinar!
🎉 Cheers to 15 years of patient recruitment and retention innovation and impact at Innovative Trials! 🎉 From 2010 to 2025, we’ve been on an incredible journey of growth, impact,…
John Watkinson is the new Non-Exec Chair as Innovative Trials targets significant business growth
